Clinical Trial Search Results for "ASSENT 1-TIMI 10C"
Van de Werf, F., Cannon, C. P., Luyten, A., Houbracken, K., McCabe, C. H., Berioli, S., Bluhmki, E., Sarelin, H., Wang-Clow, F., Fox, N. L., Braunwald, E. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators Am Heart J. 1999;137(5):786-91. Abstract
Wang-Clow, F., Fox, N. L., Cannon, C. P., Gibson, C. M., Berioli, S., Bluhmki, E., Danays, T., Braunwald, E., Van De Werf, F., Stump, D. C. Determination of a weight-adjusted dose of TNK-tissue plasminogen activator Am Heart J. 2001;141(1):33-40. Abstract
SEARCH BY:
For more information about enrolling in a clinical trial, participating in a clinical trial, or starting a new clinical trial contact smchale@partners.org or 617.278.0145.